Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
•
Internal Medicine
Do you routinely use oral vancomycin prophylaxis in patients with a history of CDI who are receiving antibiotics?
Related Questions
Do you use CNS dosing of antibiotics for any portion of the treatment course in patients with infective endocarditis who have cerebral emboli?
Do you use oral beta-lactams to treat osteomyelitis?
How would you manage a patient with brucella melitensis abscess in whom surgery was initially deferred, developed worsening lower extremity numbness and weakness and MRI findings despite 1 month of combination therapy with ceftriaxone, rifampin, and doxycycline, and who is now readmitted to hospital following surgical washout?
For a patient on appropriate treatment for invasive aspergillosis, how do you determine if and when it is acceptable to reintroduce a TNF inhibitor that likely contributed to their acquisition of the infection but is considered essential for control of their inflammatory condition?
How do you approach recommending ocular exams for asymptomatic candidemic patients considering the discordance between the IDSA and American Academy of Ophthalmology guidelines?
Would you give long term antistreptococcal antibiotic prophylaxis to a patient who presents with features of poststreptococcal reactive arthritis but who also meets criteria for Acute Rheumatic Fever?
Would you consider leaving fever untreated in patients with sepsis to potentially enhance immune responses and antimicrobial efficacy?
Do you recommend to exchange nephrostomy tubes when a patient is diagnosed with a urinary tract infection in the absence of any overt signs of infection at the exit site?
Do you routinely recommend D-mannose or probiotics for patients with recurrent urinary tract infections?
Do you consider repeat RSV vaccination in subsequent pregnancy for select patients at high risk of severe infection and/or whose previous infant experienced severe RSV infection?
